Resistance of paroxysmal nocturnal hemoglobinuria cells to the glycosylphosphatidylinositol-binding toxin aerolysin

Blood

Volumn 93, Issue 5, 1999, Pages 1749-1756

  Brodsky, Robert A ^a   Mukhina, Galina L ^b   Nelson, Kim L ^b   Lawrence, Tracy S ^b   Jones, Richard J ^b   Buckley, J Thomas ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; GLYCOSYLPHOSPHATIDYLINOSITOL;

ARTICLE; CELL KINETICS; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY; ERYTHROCYTE; FLOW CYTOMETRY; GRANULOCYTE; HEMOLYSIS; HUMAN; HUMAN CELL; LYMPHOCYTE; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PRIORITY JOURNAL;

EID: 0033105696     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.5.1749     Document Type: Article

References (37)

1. Rosse WF: Paroxysmal nocturnal hemoglobinuria as a molecular disease. Medicine 76:63, 1997
2. Miyata T, Takeda J, Iida Y, Yamada N, Inoue M, Takahashi M, Maeda K, Kitani T, Kinoshita T: The cloning of PIG-A, a component in the early step of GPI-anchor biosynthesis. Science 259:1318, 1993
3. Takeda J, Miyata T, Kawagoe K, Iida Y, Endo Y, Fujita T, Takahashi M, Kitani T, Kinoshita T: Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell 73:703, 1993
4. Miyata T, Yamada N, Iida Y, Nishimura J, Takeda J, Kitani T, Kinoshita T: Abnormalities of PIG-A transcripts in granulocytes from patients with paroxysmal nocturnal hemoglobinuria. N Engl J Med 330:249, 1994
5. Bessler M, Mason PJ, Hillmen P, Miyata T, Yamada N, Takeda J, Luzzatto L, Kinoshita T: Paroxysmal nocturnal haemoglobinuria (PNH) is caused by somatic mutations in the PIG-A gene. EMBO J 13:110, 1994
6. Robinson PJ: Phosphatidylinositol membrane anchors and T-cell activation [review]. Immunol Today 12:35, 1991
7. Stefanova I, Horejsi V, Ansotegui IJ, Knapp W, Stockinger H: GPI-anchored cell-surface molecules complexed to protein tyrosine kinases. Science 254:1016, 1991
8. Brown DA, Crise B, Rose JK: Mechanism of membrane anchoring affects polarized expression of two proteins in MDCK cells. Science 245:1499, 1989
9. Powell SK, Cunningham BA, Edelman GM, Rodriguez-Boulan E: Targeting of transmembrane and GPI-anchored forms of N-CAM to opposite domains of a polarized epithelial cell. Nature 353:76, 1991
10. Brodsky RA, Vala MS, Barber JP, Medof ME, Jones RJ: Resistance to apoptosis caused by PIG-A gene mutations in paroxymal nocturnal hemoglobinuria. Proc Natl Acad Sci USA 94:8756, 1997
11. Rosse WF: Treatment of paroxysmal nocturnal hemoglobinuria. Blood 60:20, 1982
12. Rosse WF, Ware RE: The molecular basis of paroxysmal nocturnal hemoglobinuria. Blood 86:3277, 1995
13. Parker MW, van der Goot FG, Buckley JT: Aerolysin - The ins and outs of a model channel-forming toxin. Mol Microbiol 19:205, 1996
14. Howard SP, Buckley JT: Activation of the hole-forming toxin aerolysin by extracellular processing. J Bacteriol 163:336, 1985
15. Garland WJ, Buckley JT: The cytolytic toxin aerolysin must aggregate to disrupt erythrocytes, and aggregation is stimulated by human glycophorin. Infect Immunity 56:1249, 1988
16. Howard SP, Buckley JT: Membrane glycoprotein receptor and hole forming properties of a cytolytic protein toxin. Biochemistry 21:1662, 1982
17. van der Goot FG, Pattus F, Wong K, Buckley JT: Oligomerization of the channel-forming toxin aerolysin precedes insertion into lipid bilayers. Biochemistry 32:2636, 1993
18. Cowell S, Wolfgang A, Gruber HJ, Nelson KL, Buckley JT: The erythrocyte receptor for the channel-forming toxin aerolysin is a novel glycosylphosphatidylinositol-anchored protein. Mol Microbiol 25:343, 1997
19. Nelson KL, Raja SM, Buckley JT: The glycosylphosphatidylinositol-anchored surface glycoprotein Thy-1 is a receptor for the channel-forming toxin aerolysin. J Biol Chem 272:12170, 1997
20. Diep DB, Nelson KL, Raja SM, Pleshak EN, Buckley JT: Glycosylphosphatidylinositol anchors of membrane glycoproteins are binding determinants for the channel-forming toxin aerolysin. J Biol Chem 273:2355, 1998
21. Hollander N, Selvaraj P, Springer TA: Biosynthesis and function of LFA-3 in human mutant cells deficient in phosphatidylinositol-anchored proteins. J Immunol 141:4283, 1988
22. Colotta F, Re F, Polentarutti N, Sozzani S, Mantovani A: Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 80:2012, 1992
23. Neville DM: Molecular weight determination of protein dodecyl suplhate complexes by gel electrophoresis in a discontinuous buffer system. J Biol Chem 246:6328, 1971
24. Schubert J, Alvarado M, Uciechowski P, Zielinska-Skowronek M, Freund M, Vogt H, Schmidt RE: Diangosis of paroxysmal nocturnal haemoglobinuria using immunophenotyping of peripheral blood cells. Br J Haematol 79:487, 1991
25. Hall SE, Rosse WF: The use of monoclonal antibodies and flow cytometry in the diagnosis of paroxysmal nocturnal hemoglobinuria. Blood 87:5332, 1996
26. Horikawa K, Nakakuma H, Kawaguchi T, Iwamoto N, Nagakura S, Kagimoto T, Takatsuki K: Apoptosis resistance of blood cells from patients with paroxysmal nocturnal hemoglobinuria, aplastic anemia, and myelodysplastic syndrome. Blood 90:2716, 1997
27. Brubaker LH, Essig LJ, Mengel CE: Neutrophil life span in paroxysmal nocturnal hemoglobinuria. Blood 50:657, 1977
28. Rosse WF: The life-span of complement-sensitive and -insensitive red cells in paroxysmal nocturnal hemoglobinuria. Blood 37:556, 1971
29. Nagarajan S, Brodsky R, Young NS, Medof ME: Genetic defects underlying paroxysmal nocturnal hemoglobinuria that arises out of aplastic anemia. Blood 86:4656, 1995
30. Griscelli-Bennaceur A, Gluckman E, Scrobohaci ML, Jonveaux P, Vu T, Bazarbachi A, Carosella ED, Sigaux F, Socie G: Aplastic anemia and paroxysmal nocturnal hemoglobinuria: Search for a pathogenetic link. Blood 85:1354, 1995
31. Socie G, Mary JY, de Gramont A, Rio B, Leporrier M, Rose C, Heudier P, Rochant H, Cahn JY, Gluckman E: Paroxysmal nocturnal haemoglobinuria: Long-term follow-up and prognostic factors. French Society of Haematology. Lancet 348:573, 1996
32. Brodsky RA, Sensenbrenner LL, Jones RJ: Complete remission in acquired severe aplastic anemia following high-dose cyclophosphamide. Blood 87:491, 1996
33. Socie G, Henry-Amar M, Bacigalupo A, Hows JM, Tichelli A, Ljungman P, McCann SR, Frickhofen N, Van't Veer-Korthof E, Gluckman E: Malignant tumors occuring after treatment of aplastic anemia. N Engl J Med 329:1152, 1993
34. Dameshek W: Riddle: What do aplastic anemia, paroxysmal nocutrnal hemoglobinuria (PNH) and "hypoplastic" leukemia have in common? (editorial). Blood 30:251, 1967
35. Rotoli B, Luzzatto L: Paroxysmal nocturnal haemoglobinuria. Clin Haematol 2:113, 1989
36. Young NS: The problem of clonality in aplastic anemia: Dr. Dameshek's riddle, restated. Blood 79:1385, 1992
37. Luzzatto L, Bessler M, Rotoli B: Somatic mutations in paroxysmal nocturnal hemoglobinuria: A blessing in disguise? Cell 88:1, 1997